As of 2025-09-15, the Relative Valuation of Edgewise Therapeutics Inc (EWTX) is (28.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.24 USD, the upside of Edgewise Therapeutics Inc based on Relative Valuation is -300.4%.
The range of the Relative Valuation is (27.29) - (29.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 20.4x | 18.9x |
| Forward P/E multiples | 19.1x - 21.6x | 21.0x |
| Fair Price | (27.29) - (29.21) | (28.54) |
| Upside | -291.7% - -305.1% | -300.4% |
| Date | P/E |
| 2025-09-11 | -10.26 |
| 2025-09-10 | -10.26 |
| 2025-09-09 | -10.31 |
| 2025-09-08 | -10.40 |
| 2025-09-05 | -10.88 |
| 2025-09-04 | -10.22 |
| 2025-09-03 | -10.23 |
| 2025-09-02 | -10.39 |
| 2025-08-29 | -10.03 |
| 2025-08-28 | -10.24 |
| 2025-08-27 | -10.10 |
| 2025-08-26 | -10.21 |
| 2025-08-25 | -10.00 |
| 2025-08-22 | -10.38 |
| 2025-08-21 | -10.22 |
| 2025-08-20 | -9.67 |
| 2025-08-19 | -9.65 |
| 2025-08-18 | -9.79 |
| 2025-08-15 | -9.89 |
| 2025-08-14 | -9.74 |
| 2025-08-13 | -9.60 |
| 2025-08-12 | -9.36 |
| 2025-08-11 | -9.08 |
| 2025-08-08 | -8.86 |
| 2025-08-07 | -9.05 |
| 2025-08-06 | -9.45 |
| 2025-08-05 | -9.60 |
| 2025-08-04 | -9.51 |
| 2025-08-01 | -10.00 |
| 2025-07-31 | -9.97 |
| 2025-07-30 | -9.95 |
| 2025-07-29 | -9.75 |
| 2025-07-28 | -9.97 |
| 2025-07-25 | -9.87 |
| 2025-07-24 | -10.23 |
| 2025-07-23 | -10.06 |
| 2025-07-22 | -9.47 |
| 2025-07-21 | -9.36 |
| 2025-07-18 | -9.47 |
| 2025-07-17 | -9.60 |
| 2025-07-16 | -9.54 |
| 2025-07-15 | -9.35 |
| 2025-07-14 | -9.74 |
| 2025-07-11 | -9.67 |
| 2025-07-10 | -9.70 |
| 2025-07-09 | -9.85 |
| 2025-07-08 | -9.10 |
| 2025-07-07 | -8.82 |
| 2025-07-03 | -9.11 |
| 2025-07-02 | -9.09 |